| A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus. (NCT01363752) | Astellas Pharma Inc | 2011-03-08 |
| Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients (NCT01289717) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-01 |
| A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids (NCT01304836) | Astellas Pharma Inc | 2011-01-22 |
| Thymoglobulin Induction in Kidney Transplant Recipients (NCT01239563) | University of Oxford | 2011-01-01 |
| Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation (NCT01035593) | Pharming Technologies B.V. | 2010-12-01 |
| Anti-BK Virus Immune Response and Kidney Transplantation (NCT01109186) | Nantes University Hospital | 2010-11-30 |
| A Study to Assess Pharmacokinetic, Pharmacodynamic, Safety and Tolerability of ASKP1240 in de Novo Kidney Transplantation (NCT01279538) | Astellas Pharma Inc | 2010-11-17 |
| Effect of Thymoglobulin Versus Basiliximab on Regulatory T Cell Function in Live Donor Kidney Transplant Recipients (NCT02730715) | University of Pennsylvania | 2010-11-01 |
| Conventional Laparoscopic Versus Laparoendoscopic Single Site Donor Nephrectomy in Living Donor Kidney Transplantation (NCT01236326) | Weill Medical College of Cornell University | 2010-11-01 |
| Study of Sodium Bicarbonate in Kidney Transplant Recipients (NCT01225796) | University of Utah | 2010-11-01 |
| Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients (NCT01213394) | Ramesh Prasad | 2010-10-01 |
| Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy (NCT01120028) | University of Oxford | 2010-09-01 |
| Analysis of Donor Biopsy Tissue Samples at the Time of Kidney Transplant (NCT01271465) | Weill Medical College of Cornell University | 2010-09-01 |
| Associating Renal Transplantation With the ITN Signature of Tolerance (NCT01516177) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-09-01 |
| A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAF (NCT01839929) | Astellas Pharma Korea, Inc. | 2010-09-01 |
| Role of Donor Genetics and Recipient Genetics in Kidney Transplant Outcomes (NCT01143532) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2010-08-12 |
| Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant Recipients (NCT01114529) | Novartis Pharmaceuticals | 2010-08-09 |
| Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients (NCT01033500) | University of Wisconsin, Madison | 2010-07-01 |
| Medical Economic Evaluation and of Quality of Life of the Kidney Living Donors. (NCT02830568) | Central Hospital, Nancy, France | 2010-06-01 |
| Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation (NCT01149993) | Georgetown University | 2010-06-01 |
| A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen (NCT02963103) | Astellas Pharma Korea, Inc. | 2010-05-01 |
| Treatment of the optImuM Dose of calcineUrin Inhibitor and Mycophenolate Sodium in Kidney Recipients (NCT01159080) | Asan Medical Center | 2010-04-01 |
| Mucosal Response in Immunocompromised Host (NCT01109914) | Leiden University Medical Center | 2010-04-01 |
| Enhancing Donated After Cardiac Death (DCD) Utilization With Thrombolytic Therapy (NCT01197573) | The Cleveland Clinic | 2010-04-01 |
| Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney Transplantation (NCT01640743) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2010-03-01 |
| Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation (NCT01136395) | University of Giessen | 2010-01-01 |
| Diet Rich in N-3 Polyunsaturated Fatty Acids in Renal Transplant Recipients (NCT01872455) | Federico II University | 2010-01-01 |
| Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients (NCT00975000) | Amgen | 2009-12-03 |
| A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant Patients (NCT01033864) | Hoffmann-La Roche | 2009-11-01 |
| Live Kidney Donor Study -Renal Function Study (NCT01158742) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-09-01 |
| Change of Body Composition After Kidney Transplantation in Korea (NCT01157884) | Seoul National University Hospital | 2009-09-01 |
| Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts (NCT00933231) | Astellas Pharma Inc | 2009-08-17 |
| Impact of Fibroblast Growth Factor 23 (FGF-23) and Serum Phosphate on Allograft Function and Mortality in Kidney Allograft Recipients (NCT00903578) | Ramathibodi Hospital | 2009-05-01 |
| Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation (NCT00768729) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-05-01 |
| Vitamin D3 Substitution in Vitamin D Deficient Kidney Transplant Recipients (NCT00752401) | Medical University of Vienna | 2009-05-01 |
| Individually Adapted Immunosuppression in de Novo Renal Transplantation Based on Immune Function Monitoring: a Prospective Randomised Study (NCT00895206) | University Hospital, Ghent | 2009-05-01 |
| Pharmacokinetic Evaluation of an Intensified and Decreasing Dosing Regimen of Mycophenolate Sodium in Combination With Tacrolimus Post Kidney Transplant: The Myfortic Study (NCT00941824) | Centre Hospitalier Universitaire de Saint Etienne | 2009-02-01 |
| A Study of the Impact of an Early Biopsy in Patients Treated With CellCept (Mycophenolate Mofetil) After Kidney Transplantation (NCT00817687) | Hoffmann-La Roche | 2009-01-01 |
| Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation (NCT00811915) | University Hospital, Rouen | 2009-01-01 |
| Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection (NCT00801632) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-12-01 |
| Pilot Study Evaluating Doxercalciferol Replacement Therapy in Kidney Transplant Recipients (NCT00889629) | Mariana Markell | 2008-11-01 |
| Quality of Life in Pediatric Transplant Patients (NCT00678002) | Medical College of Wisconsin | 2008-10-01 |
| Vitamin D Replacement After Kidney Transplant (NCT00748618) | University of Nebraska | 2008-10-01 |
| Pharmacogenetics to Predict Drug Interactions in Kidney Transplant Recipients (NCT01288521) | Sony Tuteja | 2008-10-01 |
| Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients (NCT00820911) | Novartis Pharmaceuticals | 2008-09-01 |
| Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients (NCT00782821) | University of Cincinnati | 2008-09-01 |
| Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients (NCT00658359) | Pfizer | 2008-08-01 |
| Rapamycin and Regulatory T Cells in Kidney Transplantation (NCT01014234) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2008-07-01 |
| The Differential Effects of 3 Different Immunosuppressive (NCT00729248) | Northwestern University | 2008-07-01 |
| The Impact of Velcade(TM)on Antibody Secreting Cells in Sensitized Renal Allograft Candidates (NCT00722722) | Mayo Clinic | 2008-06-01 |
| Genomics of Chronic Renal Allograft Rejection (The GoCAR Study) (NCT00611702) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-06-01 |
| Conversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal Transplant (NCT00646737) | Novartis | 2008-05-01 |
| Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids (NCT00658320) | Novartis | 2008-02-01 |
| Phase 2 Study of the Safety of Diannexin in Kidney Transplant Recipients (NCT00615966) | Alavita Pharmaceuticals Inc | 2008-02-01 |
| A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients (NCT00543569) | Astellas Pharma Inc | 2008-02-01 |
| Calorimetry, Insulin Resistance and Energy Metabolism Study to Understand the Risk of Obesity in Kidney Transplanted Patients (NCT01800851) | University Hospital, Clermont-Ferrand | 2008-01-01 |
| HLA-Identical Sibling Renal Transplant Tolerance (NCT00619528) | Northwestern University | 2008-01-01 |
| Short Transverse Versus Conventional Hockey Stick Incision in Kidney Transplantation (NCT00592020) | Insel Gruppe AG, University Hospital Bern | 2008-01-01 |
| Rituximab for Prevention of Rejection After Renal Transplantation (NCT00565331) | Radboud University Medical Center | 2007-12-01 |
| Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting State (NCT00585468) | University of Utah | 2007-12-01 |
| A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients (NCT00717678) | Astellas Pharma Inc | 2007-12-01 |
| Is T-lymphocyte Calcineurin Phosphatase Up-regulated by Treatment With Tacrolimus? (NCT00999362) | University of Aarhus | 2007-10-01 |
| 24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients (NCT00555789) | Novartis Pharmaceuticals | 2007-10-01 |
| Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant Survival (NCT00531921) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-09-01 |
| An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant Recipients (NCT00865137) | Astellas Pharma Inc | 2007-09-01 |
| Study Of JAK3 Inhibitor For The Prevention Of Acute Rejection In Kidney Transplant Patients (NCT00556257) | Pfizer | 2007-08-01 |
| Live Kidney Donor Study (NCT00608283) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-08-01 |
| Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients (NCT00531856) | Mallinckrodt | 2007-08-01 |
| Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients (NCT00483756) | Pfizer | 2007-08-01 |
| Influence of Pioglitazone for Renal Transplant Function in Diabetics (NCT00507494) | Technische Universität Dresden | 2007-07-01 |
| IV Insulin Protocol in Diabetes and Renal Transplantation (NCT00609986) | Medical University of South Carolina | 2007-07-01 |
| A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation (NCT00481819) | Astellas Pharma Inc | 2007-07-01 |
| Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen (NCT00514514) | Novartis Pharmaceuticals | 2007-07-01 |
| Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients (NCT00504543) | Novartis Pharmaceuticals | 2007-07-01 |
| Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients (NCT00472082) | Emory University | 2007-05-01 |
| Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation (NCT00717379) | Astellas Pharma Inc | 2007-05-01 |
| Study Evaluating of Calcineurin Inhibitors Versus Sirolimus in Renal Allograft Recipient (NCT00452361) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-04-01 |
| Performance of Cimetidine-corrected MDRD Equation in Renal Transplant Patients (NCT00475059) | Centre Hospitalier Universitaire de Saint Etienne | 2007-03-01 |
| Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients (NCT00434590) | Novartis Pharmaceuticals | 2007-03-01 |
| A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients Switched From EC-MPS. (NCT00420472) | Hoffmann-La Roche | 2007-03-01 |
| Erythropoietin (EPO) and Ischemia-reperfusion After Kidney Transplantation (NCT00425698) | Hannover Medical School | 2007-02-01 |
| Renal Transporters After Renal Transplantation (NCT00427024) | University Hospital Muenster | 2007-02-01 |
| Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation (NCT00492869) | Novartis Pharmaceuticals | 2007-01-01 |
| Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation (NCT02711202) | Institute for Clinical and Experimental Medicine | 2007-01-01 |
| Study of Rituximab to Treat Chronic Renal Transplant Rejection (NCT00476164) | King's College London | 2007-01-01 |
| Observation Study for Prediction of Allograft Survival and Impact of Imaging in Kidney Transplant Recipients. (NCT03764124) | University of Liege | 2007-01-01 |
| Evaluation of the Therapeutic Benefit of an Initial Intensified Dosing Regimen of Mycophenolate Sodium Versus a Standard Regimen in Renal Transplant Patients (NCT00419926) | Novartis | 2006-12-01 |
| Cytokine Kinetics Test to Assess the Presence or Absence of Tolerance in Organ Transplant (NCT00585858) | University of Wisconsin, Madison | 2006-09-01 |
| Protective Immunity Project 01 (NCT00788021) | Emory University | 2006-09-01 |
| Infections After Renal Transplantation: Diseases Pattern in Hong Kong (NCT00498017) | Hospital Authority, Hong Kong | 2006-07-01 |
| A Study on a New Staining Method (C4d Staining) of Transplanted Kidney Biopsies (NCT00498095) | Hospital Authority, Hong Kong | 2006-07-01 |
| Urine Testing to Detect Kidney Transplant Rejection (NCT00337220) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-06-01 |
| Survey of Adherence to Immunosuppression and Other Medications in Kidney Transplant Patients (NCT00433134) | State University of New York - Downstate Medical Center | 2006-06-01 |
| Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients (NCT00780429) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2006-06-01 |
| OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients. (NCT02005562) | Hoffmann-La Roche | 2006-05-01 |
| Trial of Rituximab Given Pre-Transplant to Sensitised Live Donor Kidney Recipients (NCT00371904) | Hunter and New England Health | 2006-04-01 |
| TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic (NCT00552201) | Centre Hospitalier Universitaire, Amiens | 2006-04-01 |
| Impact of Myfortic on Gastrointestinal (GI) Prophylaxis in Maintenance Renal Transplant Patients (NCT00905242) | East Carolina University | 2006-03-01 |
| Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients (NCT00308802) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation (NCT01053221) | University of Wisconsin, Madison | 2006-03-01 |